fda and glp-1 Approves First Oral for Cardiovascular Health FDA Warns Telehealth Companies Over

If you become pregnant or plan to, stop GLP-1 therapy and contact your provider immediately

Singh, M.D., a board-certified obesity medicine doctor and system medical director for Henry Ford Healths nonsurgical weight management and obesity medicine programs, shares what you should know about the next generation of weight loss drugs

Withdraw the needle and release the skin fold

The decision between long-term and short-term use should be individualized, considering factors such as degree of obesity, presence of complications, treatment response, side effect profile, cost and insurance coverage, and patient preferences and goals

These medicines are helping millions of Americans better control blood sugar levels and achieve meaningful weight loss

Accessibility: Flexible hours, weekend availability, and responsive communication matter when youre adjusting to a new treatment